How are we diagnosing cardiometabolic risk in primary care settings?

Primary Care Diabetes

Volumn 3, Issue 1, 2009, Pages 29-35

  Gohdes, Dorothy ^a   Amundson, Helen ^a   Oser, Carrie S ^a   Helgerson, Steven D ^a   Harwell, Todd S ^a  

^a MONTANA DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES   (United States)

Author keywords

Adults; Diabetes mellitus diagnosis; Metabolic syndrome; Obesity; Overweight

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC TEST; DYSLIPIDEMIA; FAMILY HISTORY; GLUCOSE INTOLERANCE; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MEDICAL PRACTICE ACT; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; PREGNANCY DIABETES MELLITUS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ATTITUDE OF HEALTH PERSONNEL; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COUNSELING; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MONTANA; MOTIVATION; OVERWEIGHT; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 63149147142     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2008.12.002     Document Type: Article

References (28)

1. Ogden C.I., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
2. Mensah G.A., Mokdad A.H., Ford E., et al. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol. Clin. 22 (2004) 485-514
3. Olshansky S.J., Passaro D.J., Hewshow R.C., et al. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 352 (2005) 1138-1145
4. Mokdad A.H., Bowman B.A., Ford E.S., et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 286 (2001) 1195-2000
5. Wilson P.W., D'Agostino R.B., Parise H., et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
6. McLaughlin T., Abbast F., Lamendola C., and Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals. Arch. Intern. Med. 167 (2007) 642-648
7. Rosenzweig J.L., Ferannini E., Grundy S.M., et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93 10 (2008) 3671-3689
8. Reaven G.M. The metabolic syndrome: is this diagnosis necessary?. Am. J. Clin. Nutr. 83 (2006) 1237-1247
9. Ruige J.B., Mertens I., Bartholomeeusen E., et al. Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal. Obesity 14 (2006) 1250-1256
10. American Diabetes Association. Standards of medical in diabetes - 2008. Diabetes Care 31 Suppl. 1 (2008) S12-S54
11. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421.
12. Grundy S.M., Cleeman J.I., Daniels S.R., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 25 112 (2005) 2735-2752
13. Lorenzo C., Williams K., Hunt K.J., and Haffner S.M. The National Cholesterol Education Program Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30 (2007) 8-13
14. Galassi A., Reynolds K., and He J. Metabolic syndrome and the risk of cardiovascular disease: a meta-analysis. Am. J. Med. 119 (2006) 812-819
15. Mitka M. Does the metabolic syndrome really exist? Diabetes and heart groups spar over issue. JAMA 294 (2005) 2010-2013
16. Grundy S.M. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J. Am. Coll. Cardiol. 47 (2006) 1093-1100
17. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter?. Circulation 115 (2007) 1806-1811
18. Trowbridge F.L., Sofka D., Holt K., and Barlow S.E. Management of child and adolescent obesity: study design and practitioner characteristics. Pediatrics 110 (2002) 205-209
19. Asch D.A., Jedrziewski M.K., and Christakis N.A. Response rates to mail surveys published in medical journals. J. Clin. Epidemiol. 50 10 (1997) 1129-1136
20. Foster G.D., Wadden T.A., Makris A.P., et al. Primary care physicians' attitudes about obesity and its treatment. Obes. Res. 11 (2003) 1168-1177
21. Billington C.J. The challenge of obesity management in primary care. J. Am. Board Fam. Pract. 13 (2000) 222-223
22. Huang J., Yu H., Marin E., et al. Physician weight loss counseling in two public hospital primary care clinics. Acad. Med. 79 (2004) 156-161
23. O'Connor P.J., Gregg E., Rush W.A., et al. Diabetes: how are we diagnosing and initially managing it?. Ann. Fam. Med. 4 (2006) 15-22
24. Borai A., Livingstone C., and Ferns G.A. The biochemical assessment of insulin resistance. Ann. Clin. Biochem. 44 (2007) 324-342
25. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55 (2006) 1537-1548
26. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 6 (2002) 393-403
27. Lindstrom J., Ilanne-Parikka P., Peltonen M., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368 (2006) 1673-1679
28. Eckel R.H., Kahn R., Robertson R.M., and Rizza R.A. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 113 (2006) 2943-2946